Related Experiment Video
Updated: Jul 8, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Medical decision analysis in infectious diseases
1Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario.
Summary
Medical decision analysis (MDA) offers a structured approach for infectious disease decisions. This framework can utilize costs and complications, not just utilities, aiding clinical practice.
Area of Science:
- Infectious Diseases
- Medical Decision Analysis
- Health Economics
Background:
- Medical decision analysis (MDA) is crucial for complex infectious disease management.
- Clinicians express discomfort with MDA, especially utility-based outcome measures.
- Alternative outcome variables like costs and complications can be employed in MDA.
Purpose of the Study:
- To enhance understanding of MDA's role in clinical infectious disease practice.
- To review the fundamental principles of MDA.
- To illustrate MDA application with a common clinical example.
Main Methods:
- Review of MDA principles relevant to infectious diseases.
- Discussion of alternative outcome measures beyond utilities.
- Application of a clinical case example for illustration.
Main Results:
- MDA provides an explicit, reproducible analytic framework for infectious diseases.
- The framework supports cost-effectiveness analyses and risk-benefit assessments.
- MDA can be adapted to various clinical scenarios in infectious disease.
Conclusions:
- MDA is a valuable tool for infectious disease physicians facing complex decisions.
- Understanding MDA principles and flexible outcome measures improves its clinical utility.
- This paper aims to demystify MDA for infectious disease clinicians.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:12Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:18Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...